Familial gastric cancer: detection of a hereditary cause helps to understand its etiology
Tóm tắt
Worldwide, gastric cancer is one of the most common forms of cancer, with a high morbidity and mortality. Several environmental factors predispose to the development of gastric cancer, such as
Từ khóa
Tài liệu tham khảo
Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005, 55: 74–108. 10.3322/canjclin.55.2.74
Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P: Cancer incidence in Five Continents. Lyon, France: IARC Scientific publication; 2007.
Yamaoka Y, Kato M, Asaka M: Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 2008, 47: 1077–1083. 10.2169/internalmedicine.47.0975
Bosman FT, Carneiro F, Hruban RH, Theise ND: WHO Classification of Tumours of the Digestive System. 4th edition. Lyon, France: IARC; 2010.
Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965, 64: 31–49.
Pisani P, Bray F, Parkin DM: Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002, 97: 72–81. 10.1002/ijc.1571
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El-Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V: A review of human carcinogens--Part B: biological agents. Lancet Oncol 2009, 10: 321–322. 10.1016/S1470-2045(09)70096-8
Correa P: Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992, 52: 6735–6740.
Helicobacter and Cancer Collaborative Group: Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001, 49: 347–353. 10.1136/gut.49.3.347
no authors listed: Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994, 61: 177–240.
Suerbaum S, Michetti P: Helicobacter pylori infection. N Engl J Med 2002, 347: 1175–1186. 10.1056/NEJMra020542
Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N: Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008, 19: 689–701. 10.1007/s10552-008-9132-y
Gonzalez CA, Lopez-Carrillo L: Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis. Scand J Gastroenterol 2010, 45: 6–14. 10.3109/00365520903401959
La Vecchia C, Negri E, Franceschi S, Gentile A: Family history and the risk of stomach and colorectal cancer. Cancer 1992, 70: 50–55. 10.1002/1097-0142(19920701)70:1<50::AID-CNCR2820700109>3.0.CO;2-I
Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH: Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994, 86: 1600–1608. 10.1093/jnci/86.21.1600
Stone J, Bevan S, Cunningham D, Hill A, Rahman N, Peto J, Marossy A, Houlston RS: Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer. Br J Cancer 1999, 79: 1935–1937. 10.1038/sj.bjc.6690308
Kaurah P, MacMillan A, Boyd N, Senz J, De LA, Chun N, Suriano G, Zaor S, Van ML, Gilpin C, et al.: Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007, 297: 2360–2372. 10.1001/jama.297.21.2360
Oliveira C, Senz J, Kaurah P, Pinheiro H, Sanges R, Haegert A, Corso G, Schouten J, Fitzgerald R, Vogelsang H, et al.: Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009, 18: 1545–1555. 10.1093/hmg/ddp046
Corso G, Pedrazzani C, Pinheiro H, Fernandes E, Marrelli D, Rinnovati A, Pascale V, Seruca R, Oliveira C, Roviello F: E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer 2011, 47: 631–639. 10.1016/j.ejca.2010.10.011
Park YJ, Shin KH, Park JG: Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res 2000, 6: 2994–2998.
Capelle LG, Van Grieken NC, Lingsma HF, Steyerberg EW, Klokman WJ, Bruno MJ, Vasen HF, Kuipers EJ: Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 2010, 138: 487–492. 10.1053/j.gastro.2009.10.051
Sereno M, Aguayo C, Guillen PC, Gomez-Raposo C, Zambrana F, Gomez-Lopez M, Casado E: Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention. Clin Transl Oncol 2011, 13: 599–610. 10.1007/s12094-011-0705-y
van Lier MG, Westerman AM, Wagner A, Looman CW, Wilson JH, de Rooij FW, Lemmens VE, Kuipers EJ, Mathus-Vliegen EM, van Leerdam ME: High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut 2011, 60: 141–147. 10.1136/gut.2010.223750
Oliveira C, Ferreira P, Nabais S, Campos L, Ferreira A, Cirnes L, Alves CC, Veiga I, Fragoso M, Regateiro F, et al.: E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer 2004, 40: 1897–1903. 10.1016/j.ejca.2004.04.027
Keller G, Vogelsang H, Becker I, Plaschke S, Ott K, Suriano G, Mateus AR, Seruca R, Biedermann K, Huntsman D, et al.: Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet 2004, 41: e89. 10.1136/jmg.2003.015594
Masciari S, Dewanwala A, Stoffel EM, Lauwers GY, Zheng H, Achatz MI, Riegert-Johnson D, Foretova L, Silva EM, Digianni L, et al.: Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med 2011, 13: 651–657. 10.1097/GIM.0b013e31821628b6
Jakubowska A, Nej K, Huzarski T, Scott RJ, Lubinski J: BRCA2 gene mutations in families with aggregations of breast and stomach cancers. Br J Cancer 2002, 87: 888–891. 10.1038/sj.bjc.6600562
Friedenson B: BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. MedGenMed 2005, 7: 60.
Iwama T, Mishima Y, Utsunomiya J: The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg 1993, 217: 101–108. 10.1097/00000658-199302000-00002
Park SY, Ryu JK, Park JH, Yoon H, Kim JY, Yoon YB, Park JG, Lee SH, Kang SB, Park JW, Oh JH: Prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in korean patients with familial adenomatous polyposis. Gut Liver 2011, 5: 46–51. 10.5009/gnl.2011.5.1.46
Lynch HT, Snyder C, Davies JM, Lanspa S, Lynch J, Gatalica Z, Graeve V, Foster J: FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review. Fam Cancer 2010, 9: 581–588. 10.1007/s10689-010-9352-7
Win AK, Hopper JL, Jenkins MA: Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis. Fam Cancer 2011, 10: 1–9.
Pollock J, Welsh JS: Clinical cancer genetics: Part I: Gastrointestinal. Am J Clin Oncol 2011, 34: 332–336. 10.1097/COC.0b013e3181dea432
Stanich PP, Francis DL, Sweetser S: The spectrum of findings in Cowden syndrome. Clin Gastroenterol Hepatol 2011, 9: e2-e3. 10.1016/j.cgh.2010.07.003
Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT: Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol 2000, 157: 747–754. 10.1016/S0002-9440(10)64588-9
Koornstra JJ, Mourits MJ, Sijmons RH, Leliveld AM, Hollema H, Kleibeuker JH: Management of extracolonic tumours in patients with Lynch syndrome. Lancet Oncol 2009, 10: 400–408. 10.1016/S1470-2045(09)70041-5
Lynch HT, Grady W, Suriano G, Huntsman D: Gastric cancer: new genetic developments. J Surg Oncol 2005, 90: 114–133. 10.1002/jso.20214
Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE: E-cadherin germline mutations in familial gastric cancer. Nature 1998, 392: 402–405. 10.1038/32918
Berx G, Becker KF, Hofler H, van RF: Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998, 12: 226–237. 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D
Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, van Krieken JH, et al.: Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 2010, 47: 436–444. 10.1136/jmg.2009.074237
Carneiro F, Oliveira C, Suriano G, Seruca R: Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer. J Clin Pathol 2008, 61: 25–30.
Pharoah PD, Guilford P, Caldas C: Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001, 121: 1348–1353. 10.1053/gast.2001.29611
Blair V, Martin I, Shaw D, Winship I, Kerr D, Arnold J, Harawira P, McLeod M, Parry S, Charlton A, et al.: Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol 2006, 4: 262–275. 10.1016/j.cgh.2005.12.003
Humar B, Guilford P: Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci 2009, 100: 1151–1157. 10.1111/j.1349-7006.2009.01163.x
Nejsum LN, Nelson WJ: A molecular mechanism directly linking E-cadherin adhesion to initiation of epithelial cell surface polarity. J Cell Biol 2007, 178: 323–335. 10.1083/jcb.200705094
Drubin DG, Nelson WJ: Origins of cell polarity. Cell 1996, 84: 335–344. 10.1016/S0092-8674(00)81278-7
Lechler T, Fuchs E: Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 2005, 437: 275–280. 10.1038/nature03922
Lu B, Roegiers F, Jan LY, Jan YN: Adherens junctions inhibit asymmetric division in the Drosophila epithelium. Nature 2001, 409: 522–525. 10.1038/35054077
Norton JA, Ham CM, Van DJ, Jeffrey RB, Longacre TA, Huntsman DG, Chun N, Kurian AW, Ford JM: CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 2007, 245: 873–879. 10.1097/01.sla.0000254370.29893.e4
Fitzgerald RC, Caldas C: E-cadherin mutations and hereditary gastric cancer: prevention by resection? Dig Dis 2002, 20: 23–31. 10.1159/000063162
Miholic J, Meyer HJ, Muller MJ, Weimann A, Pichlmayr R: Nutritional consequences of total gastrectomy: the relationship between mode of reconstruction, postprandial symptoms, and body composition. Surgery 1990, 108: 488–494.
Cisco RM, Ford JM, Norton JA: Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer 2008, 113: 1850–1856. 10.1002/cncr.23650
Barber ME, Save V, Carneiro F, Dwerryhouse S, Lao-Sirieix P, Hardwick RH, Caldas C, Fitzgerald RC: Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. J Pathol 2008, 216: 286–294. 10.1002/path.2415
Charlton A, Blair V, Shaw D, Parry S, Guilford P, Martin IG: Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004, 53: 814–820. 10.1136/gut.2002.010447
Sano T, Kobori O, Muto T: Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg 1992, 79: 241–244. 10.1002/bjs.1800790319
Lee AF, Rees H, Owen DA, Huntsman DG: Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers. Am J Surg Pathol 2010, 34: 1007–1013. 10.1097/PAS.0b013e3181e28985
Park CM, Reid PE, Walker DC, MacPherson BR: A simple, practical 'swiss roll' method of preparing tissues for paraffin or methacrylate embedding. J Microsc 1987, 145: 115–120. 10.1111/j.1365-2818.1987.tb01321.x
Chun YS, Lindor NM, Smyrk TC, Petersen BT, Burgart LJ, Guilford PJ, Donohue JH: Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer 2001, 92: 181–187. 10.1002/1097-0142(20010701)92:1<181::AID-CNCR1307>3.0.CO;2-J
Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, Monaghan KG, Maung R, Seruca R, Jackson CE, Caldas C: Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001, 344: 1904–1909. 10.1056/NEJM200106213442504
Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, Caldas C, Sobrinho-Simoes M: Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 2004, 203: 681–687. 10.1002/path.1564
Oliveira C, Seruca R, Carneiro F: Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 2006, 14: 21–33. 10.1177/106689690601400105
Kluijt I, Sijmons RH, Hoogerbrugge N, Plukker JT, De JD, van Krieken JH, Van HR, Ligtenberg M, Bleiker E, Cats A: Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance. Fam Cancer 2012, 11: 363–369. 10.1007/s10689-012-9521-y